메뉴 건너뛰기




Volumn 17, Issue 8, 2015, Pages 661-670

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DOXORUBICIN; GEMCITABINE; GITR LIGAND FUSION PROTEIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; OX40 LIGAND; OX40 LIGAND FUSION PROTEIN; OXALIPLATIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 1 ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; MACROGOL DERIVATIVE;

EID: 84963969143     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2015.08.004     Document Type: Article
Times cited : (140)

References (38)
  • 2
    • 84879599112 scopus 로고    scopus 로고
    • At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
    • Callahan MK, Wolchok JD At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 2013, 94:41-53.
    • (2013) J Leukoc Biol , vol.94 , pp. 41-53
    • Callahan, M.K.1    Wolchok, J.D.2
  • 3
    • 84884586706 scopus 로고    scopus 로고
    • Checkpoint modulation in melanoma: an update on ipilimumab and future directions
    • Page DB, Postow MA, Callahan MK, Wolchok JD Checkpoint modulation in melanoma: an update on ipilimumab and future directions. Curr Oncol Rep 2013, 15:500-508.
    • (2013) Curr Oncol Rep , vol.15 , pp. 500-508
    • Page, D.B.1    Postow, M.A.2    Callahan, M.K.3    Wolchok, J.D.4
  • 5
    • 84897854198 scopus 로고    scopus 로고
    • PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer
    • Guo Z, Wang X, Cheng D, Xia Z, Luan M, Zhang S PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer. PLoS One 2014, 9:e89350.
    • (2014) PLoS One , vol.9 , pp. e89350
    • Guo, Z.1    Wang, X.2    Cheng, D.3    Xia, Z.4    Luan, M.5    Zhang, S.6
  • 8
    • 84893683548 scopus 로고    scopus 로고
    • Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
    • [5876-12-36]
    • Lu L, Xu X, Zhang B, Zhang R, Ji H, Wang X Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs. J Transl Med 2014, 12:36. [5876-12-36].
    • (2014) J Transl Med , vol.12 , pp. 36
    • Lu, L.1    Xu, X.2    Zhang, B.3    Zhang, R.4    Ji, H.5    Wang, X.6
  • 10
    • 84927666190 scopus 로고    scopus 로고
    • The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4
    • Liu L, Mayes PA, Eastman S, Shi H, Yadavilli S, Zhang T, Yang J, Seestaller-Wehr L, Zhang SY, Hopson C, et al. The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4. Clin Cancer Res 2015, 21:1639-1651.
    • (2015) Clin Cancer Res , vol.21 , pp. 1639-1651
    • Liu, L.1    Mayes, P.A.2    Eastman, S.3    Shi, H.4    Yadavilli, S.5    Zhang, T.6    Yang, J.7    Seestaller-Wehr, L.8    Zhang, S.Y.9    Hopson, C.10
  • 12
    • 2642566088 scopus 로고    scopus 로고
    • Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
    • Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56:185-229.
    • (2004) Pharmacol Rev , vol.56 , pp. 185-229
    • Minotti, G.1    Menna, P.2    Salvatorelli, E.3    Cairo, G.4    Gianni, L.5
  • 13
    • 0033006172 scopus 로고    scopus 로고
    • A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
    • Gewirtz DA A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999, 57:727-741.
    • (1999) Biochem Pharmacol , vol.57 , pp. 727-741
    • Gewirtz, D.A.1
  • 14
    • 79960426821 scopus 로고    scopus 로고
    • Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors
    • Mattarollo SR, Loi S, Duret H, Ma Y, Zitvogel L, Smyth MJ Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res 2011, 71:4809-4820.
    • (2011) Cancer Res , vol.71 , pp. 4809-4820
    • Mattarollo, S.R.1    Loi, S.2    Duret, H.3    Ma, Y.4    Zitvogel, L.5    Smyth, M.J.6
  • 15
    • 34547102216 scopus 로고    scopus 로고
    • Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect
    • Zhu S, Waguespack M, Barker SA, Li S Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. Clin Cancer Res 2007, 13:4252-4260.
    • (2007) Clin Cancer Res , vol.13 , pp. 4252-4260
    • Zhu, S.1    Waguespack, M.2    Barker, S.A.3    Li, S.4
  • 19
    • 41549145181 scopus 로고    scopus 로고
    • Immunogenicity of anthracyclines: moving towards more personalized medicine
    • Apetoh L, Mignot G, Panaretakis T, Kroemer G, Zitvogel L Immunogenicity of anthracyclines: moving towards more personalized medicine. Trends Mol Med 2008, 14:141-151.
    • (2008) Trends Mol Med , vol.14 , pp. 141-151
    • Apetoh, L.1    Mignot, G.2    Panaretakis, T.3    Kroemer, G.4    Zitvogel, L.5
  • 21
    • 0027213484 scopus 로고
    • Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes
    • Williams SS, Alosco TR, Mayhew E, Lasic DD, Martin FJ, Bankert RB Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res 1993, 53:3964-3967.
    • (1993) Cancer Res , vol.53 , pp. 3964-3967
    • Williams, S.S.1    Alosco, T.R.2    Mayhew, E.3    Lasic, D.D.4    Martin, F.J.5    Bankert, R.B.6
  • 22
    • 0029741953 scopus 로고    scopus 로고
    • Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts
    • Sakakibara T, Chen FA, Kida H, Kunieda K, Cuenca RE, Martin FJ, Bankert RB Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. Cancer Res 1996, 56:3743-3746.
    • (1996) Cancer Res , vol.56 , pp. 3743-3746
    • Sakakibara, T.1    Chen, F.A.2    Kida, H.3    Kunieda, K.4    Cuenca, R.E.5    Martin, F.J.6    Bankert, R.B.7
  • 26
  • 28
    • 38549148416 scopus 로고    scopus 로고
    • Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects
    • Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects. Cancer Biol Ther 2007, 6:880-885.
    • (2007) Cancer Biol Ther , vol.6 , pp. 880-885
    • Suzuki, E.1    Sun, J.2    Kapoor, V.3    Jassar, A.S.4    Albelda, S.M.5
  • 30
    • 0343923453 scopus 로고    scopus 로고
    • Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals
    • Gabizon A, Goren D, Horowitz A, Tzemach D, Lossos A, Siegal T Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev 1997, 24:337-344.
    • (1997) Adv Drug Deliv Rev , vol.24 , pp. 337-344
    • Gabizon, A.1    Goren, D.2    Horowitz, A.3    Tzemach, D.4    Lossos, A.5    Siegal, T.6
  • 31
    • 0347626100 scopus 로고    scopus 로고
    • Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model
    • Hermans IF, Chong TW, Palmowski MJ, Harris AL, Cerundolo V Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Cancer Res 2003, 63:8408-8413.
    • (2003) Cancer Res , vol.63 , pp. 8408-8413
    • Hermans, I.F.1    Chong, T.W.2    Palmowski, M.J.3    Harris, A.L.4    Cerundolo, V.5
  • 32
    • 84865553173 scopus 로고    scopus 로고
    • Combination immunotherapy approaches
    • viii41-viii46
    • Drake CG Combination immunotherapy approaches. Ann Oncol 2012, 23(Suppl. 8):viii41-viii46.
    • (2012) Ann Oncol , vol.23
    • Drake, C.G.1
  • 33
    • 33746115391 scopus 로고    scopus 로고
    • CD80 in immune suppression by mouse ovarian carcinoma-associated gr-1 + CD11b + myeloid cells
    • Yang R, Cai Z, Zhang Y, Yutzy WH, Roby KF, Roden RB CD80 in immune suppression by mouse ovarian carcinoma-associated gr-1 + CD11b + myeloid cells. Cancer Res 2006, 66:6807-6815.
    • (2006) Cancer Res , vol.66 , pp. 6807-6815
    • Yang, R.1    Cai, Z.2    Zhang, Y.3    Yutzy, W.H.4    Roby, K.F.5    Roden, R.B.6
  • 38
    • 78449244037 scopus 로고    scopus 로고
    • The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications
    • Di Giacomo AM, Biagioli M, Maio M The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications. Semin Oncol 2010, 37:499-507.
    • (2010) Semin Oncol , vol.37 , pp. 499-507
    • Di Giacomo, A.M.1    Biagioli, M.2    Maio, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.